Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfenex Inc (NYSE MKT LLC:PFNX)

8.08
Delayed Data
As of Jan 20
 -0.09 / -1.10%
Today’s Change
5.79
Today|||52-Week Range
11.35
-10.92%
Year-to-Date
No recent news for Pfenex Inc.

Today’s Trading

Previous close8.17
Today’s open8.12
Day’s range7.74 - 8.21
Volume98,515
Average volume (3 months)65,896
Market cap$189.2M
Dividend yield--
Data as of 4:02pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-21.15%
Earnings growth (this year)+103.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.97%
P/E ratio26.1
Price/Sales28.91
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
ENZYEnzymotec Ltd+0.05+0.63%
CBMGCellular Biomedicine...-0.10-0.79%
OSIROsiris Therapeutics ...+0.13+2.65%
RXDXIgnyta Inc0.000.00%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$9.6M
Annual profit (last year)-$28.2M
Net profit margin-294.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Class III Director
Bertrand C. Liang
Vice President-
Operations
Henry W. Talbot
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs